Home › Funds › Caligan Partners LP › ANIK
Caligan Partners LP position in ANIK
ANIKA THERAPEUTICS INC · Health Care
Caligan Partners LP reported holding 1,435,130 shares of ANIK (ANIKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.0M, representing 1.23% of its reported portfolio and ranking #18 among its reported holdings. Caligan Partners LP has disclosed ANIK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Caligan Partners LP's ANIK position evolved
Caligan Partners LP first disclosed a stake in ANIK in Q3 2023 at 1,081,360 shares (US$20.1M). The position peaked in Q1 2024 at 1,435,993 shares, worth US$36.5M. Across 12 filings, Caligan Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 1,435,130 shares valued at US$21.0M. Notable position changes include a 33% increase in Q1 2024 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.08M | $20.15M | New |
| Q4 2023 | 1.08M | $24.50M | Hold |
| Q1 2024 | 1.44M | $36.47M | Add |
| Q2 2024 | 1.44M | $36.37M | Hold |
| Q3 2024 | 1.44M | $35.45M | Hold |
| Q4 2024 | 1.44M | $23.62M | Hold |
| Q1 2025 | 1.44M | $21.57M | Hold |
| Q2 2025 | 1.44M | $15.18M | Hold |
| Q3 2025 | 1.44M | $13.49M | Hold |
| Q4 2025 | 1.44M | $13.79M | Hold |
| Q1 2026 | 1.44M | $20.81M | Hold |
| Q2 2026 | 1.44M | $21.00M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIK and 13F data
ANIK (ANIKA THERAPEUTICS INC) is a Health Care company. 19 other funds we track also report a position in ANIK — the largest reported positions include CAPITAL MANAGEMENT CORP /VA (US$6.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIK
- CAPITAL MANAGEMENT CORP /VA 448.47K sh · $6.56M · Q2 2026
More on Caligan Partners LP
FAQ
How long has Caligan Partners LP held ANIK?
Caligan Partners LP has disclosed ANIK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Caligan Partners LP's current position in ANIK?
As of Q2 2026, Caligan Partners LP holds 1.44M shares of ANIK (ANIKA THERAPEUTICS INC), valued at $21.00M, representing 1.23% of its reported portfolio and ranking #18.
Has Caligan Partners LP been buying or selling ANIK?
In the latest 13F filing (Q2 2026), Caligan Partners LP held unchanged its position in ANIK. The position peaked in Q1 2024 at 1.44M shares.
Which other funds hold ANIK?
Other major institutional holders of ANIK include CAPITAL MANAGEMENT CORP /VA, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.